Beeline Announces Public Launch of MagicBlocks, an AI-Powered Sales Agent Platform
Beeline Holdings, Inc (NASDAQ:BLNE)
'MagicBlocks represents a breakthrough in AI-driven sales efficiency,' said Nick Liuzza, of Beeline. 'With its strong Beta results, we're happy to see it go to market as an international solution.' — Nick Liuzza
PROVIDENCE, RI, UNITED STATES, March 20, 2025 / EINPresswire.com / -- Beeline Holdings, Inc. (Nasdaq: BLNE), an emerging FinTech mortgage lender, announces the official public launch of MagicBlocks, an AI-driven sales agent platform, on April 1, 2025. Incubated by Beeline, MagicBlocks successfully completed its Beta phase with 16 clients, exceeding expectations and validating its market potential as a global solution open to businesses worldwide.
MagicBlocks was founded by Jay Stockwell and Sean Calark while at Beeline and was spun off as an independent company. Beeline retains an equity stake, while Stockwell serves as CEO. Beeline also licenses the MagicBlocks platform.
'MagicBlocks represents a breakthrough in AI-driven sales efficiency,' said Nick Liuzza, CEO of Beeline. 'With its strong Beta results, we're happy to see it go to market as a scalable, international solution.'
Beeline continues to expand beyond mortgage origination by integrating SaaS-based revenue streams. Most lenders license third-party software, and the ones who build their own platforms don't generally license it. Beeline is willing, leveraging its proprietary AI technology to create better outcomes for mortgage consumers while generating recurring SaaS revenue.
Earlier this year, Beeline Labs introduced BlinkQC, an automated quality control solution streamlining mortgage operations. Currently live within Beeline, BlinkQC will be available industry-wide in early April. With its AI-powered technology and market expertise, Beeline is redefining mortgage lending, combining innovation, efficiency, and strategic growth.
About Beeline
Beeline is a forward-thinking mortgage origination and technology company transforming home loans into a short, transparent and easy path for millions of Americans. Using AI and proprietary tech, Beeline offers near-instant pre-approvals in as little as seven minutes—allowing borrowers to see loan options and lock their rate in one session.
For media inquiries, please contact:
Beeline Holdings, Inc
+1 401-418-4461
email us here
Legal Disclaimer:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
32 minutes ago
- Business Insider
‘Only the Beginning,' Says Investor About AMD Stock
Advanced Micro Devices (NASDAQ:AMD) stock offered little cause for celebration in the latter half of 2024 and into 2025. Despite generating strong revenue amid the ongoing AI boom, the chipmaker's share price tumbled, leaving investors out in the cold. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. That narrative, however, has shifted sharply in recent months. AMD's share price has skyrocketed 83% over the past three months, driven by renewed market optimism, a standout Q1 2025 earnings report, continued AI infrastructure investments by hyperscalers, and a landmark contract in Saudi Arabia. In fact, one investor, known by the pseudonym Cash Flow Venue (CFV), believes that AMD's 'rally has just begun,' citing product traction and international tailwinds as signs of more upside ahead. As supporting evidence, the investor points to the growing adoption of AMD's MI series GPUs by major tech players. With the Instinct MI350 already shipping and the MI400 expected to debut in 2026, AMD's data center strategy appears to be gaining real momentum. 'AMD doesn't slow down its pace, and while it still lags behind Nvidia, it doesn't have to overthrow it to secure a strong #2 position in the market, still securing high demand, growing and profitable sales, as well as customer relationships ensuring future growth prospects,' the investor added. CFV is also buoyed by some recent regulatory developments, as the Trump administration has indicated its willingness to allow the export of advanced AI chips to China. This could reopen the door for AMD's advanced AI chips, specifically the MI308, to be exported to China. Keep on Buying AMD Stock Taken together, these developments give the investor confidence that AMD's rally still has legs, even with the stock trading at a heightened EV-to-EBITDA multiple of 36.8x. 'Given robust financials, product innovation, and renewed China access, I am raising my AMD rating to Strong Buy for continued upside potential,' exclaims CFV. (To watch Cash Flow Venue's track record, click here) Wall Street, meanwhile, shows a mixed stance. AMD holds a Moderate Buy consensus rating based on 25 Buys and 10 Holds. However, the average 12-month price target of $144.45 suggests the stock may be overvalued by ~8% at current levels. (See AMD stock forecast) To find good ideas for AI stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
an hour ago
- Yahoo
This Magnificent Tech Stock Is Soaring After Joining the S&P 500. Should You Buy It?
Key Points The Trade Desk just joined the S&P 500 index, and the news that it would gave the stock a shot in the arm. The programmatic advertising company's share price jumped impressively in the past three months, bringing its valuation to premium levels. The Trade Desk, however, has the potential to justify its valuation and sustain its impressive rally. These 10 stocks could mint the next wave of millionaires › Programmatic digital advertising provider The Trade Desk (NASDAQ: TTD) is the latest company to join the S&P 500 index, doing so on July 18. The addition explains why shares of the company shot up an impressive 6% on the day following the announcement that it would join. The spike isn't surprising; The Trade Desk's entry into the S&P 500 is a testament to the company's solid profitability and liquidity in the past four quarters. Moreover, the addition to the index has led to an increase in demand for a stock from passive investors and index funds because of a phenomenon called the "index effect." It is worth noting that The Trade Desk was selected to join the S&P 500 over popular names such as Robinhood Markets, AppLovin, Interactive Brokers, and others. It will be replacing Ansys in the index (Ansys was acquired by Synopsys). However, investors may now be wondering if it makes sense to buy The Trade Desk stock as it has shot up more than 59% in the space of just three months as of this writing. Let's see if it is a good idea to buy The Trade Desk following its inclusion in the S&P 500. The Trade Desk's valuation makes it an expensive stock to buy right now The Trade Desk's recent rally has brought the stock's price-to-earnings (P/E) ratio to 97 as of this writing. That's nearly triple the tech-laden Nasdaq-100 index's average earnings multiple. The forward earnings multiple of 45, though far lower than the trailing multiple, is still on the expensive side. Investors, therefore, will have to pay a huge premium if they are looking to buy the stock right now. For a company that's expected to deliver an increase of just 7% in earnings this year, The Trade Desk seems too richly valued to buy right now. But then, growth-oriented investors will do well to note that the company is operating in a fast-growing market that benefits from the rapid adoption of artificial intelligence (AI) tools. A huge addressable opportunity could help the stock maintain its momentum According to one estimate, the programmatic advertising market that The Trade Desk serves could grow by 10x between 2024 and 2033, generating a whopping $236 billion in revenue at the end of the forecast period. The Trade Desk has generated just under $2.6 billion in revenue in the past 12 months, indicating that it still has massive room for growth over the next decade. An important point to note here is that The Trade Desk's growth is better than that of large competitors such as Meta Platforms and Alphabet. The company reported a 25% year-over-year increase in revenue in Q1, which was well above the 16% growth in Meta's advertising business during the same quarter. Alphabet's Google advertising business, on the other hand, grew at a much slower pace of 8% in Q1. Of course, The Trade Desk is a much smaller company right now, but its robust growth suggests that it is gradually making its presence felt in the multibillion-dollar digital ad market. The company's AI tools are playing a central role in helping it register a robust growth rate, with two-thirds of its customer base currently using its Kokai programmatic advertising platform. The company points out that Kokai analyzes 17 million real-time opportunities every second to help advertisers and brands buy relevant ad inventory that can be served across different channels such as video, audio, display, social, connected TVs, and others. The data-driven advertising enables The Trade Desk to optimize campaigns so that its customers can generate higher returns on the ad dollars they spend. The Trade Desk claims that its clients who are using Kokai have seen a 42% drop in cost per unique reach, a metric that refers to the amount spent to reach a unique individual through an advertisement. Not surprisingly, the company says that its "active contract negotiations are at all-time highs." All this indicates that The Trade Desk's growth could pick up pace in the future. Consensus estimates, for instance, project its bottom-line growth rate to nearly triple to 20% in 2026 as compared to this year. The Trade Desk has the potential to maintain an upward earnings growth trajectory, as it expects the cost savings achieved by advertisers using its platform to be reinvested back into advertising campaigns. As such, don't be surprised to see an uptick in The Trade Desk's earnings growth in the long run, suggesting that the company has the ability to justify its valuation. That's why this tech stock could still attract growth investors even after the handsome gains it has clocked lately. Don't miss this second chance at a potentially lucrative opportunity Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $447,134!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $40,090!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $652,133!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of July 14, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, AppLovin, Interactive Brokers Group, Meta Platforms, Synopsys, and The Trade Desk. The Motley Fool recommends the following options: long January 2027 $175 calls on Interactive Brokers Group and short January 2027 $185 calls on Interactive Brokers Group. The Motley Fool has a disclosure policy. This Magnificent Tech Stock Is Soaring After Joining the S&P 500. Should You Buy It? was originally published by The Motley Fool
Business Upturn
2 hours ago
- Business Upturn
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the 'Class Period'), of the important August 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased Sarepta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Sarepta class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) ELEVIDYS, a prescription gene therapy intended for certain patients being treated for Duchenne muscular dystrophy, posed significant safety risks to patients; (2) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (3) the severity of adverse events from ELEVIDYS treatment would cause Sarepta to halt recruitment and dosing in ELEVIDYS trials, attract regulatory scrutiny, and create greater risk around the therapy's present and expanded approvals; and (4) as a result of the foregoing, defendants materially misled with, and/or lacked a reasonable basis for, their positive statements. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Sarepta class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
